Highest-materiality recent filing
Mettler-Toledo approves 2026 LTI awards; CEO target up 6.25%, NEOs up 12.5%
CEO Patrick Kaltenbach granted 838 PSUs, 2,005 options, 810 RSUs for May 2026 grant.
Mettler-Toledo elects all nine directors, ratifies PwC, approves say-on-pay
All nine director nominees elected with majority support; Thomas P. Salice received fewest 'for' votes (16.2M).
Mettler-Toledo Q1 adj EPS $8.91 beats $8.19 YoY; raises FY adj EPS guidance to $46.30-$46.95
Reported sales $947.1M (+7% YoY); local currency sales +3% (Americas +2%, Europe +1%, Asia/RoW +5%).
Mettler-Toledo Q4 2025 GAAP EPS $13.98, adj. EPS $13.36; guides FY2026 adj. EPS $46.05-$46.70
Q4 reported sales $1.130B, +8% YoY; local currency sales +5% including 1% acquisition benefit.
Mettler-Toledo appoints former STERIS CFO Michael Tokich to Board
Michael J. Tokich appointed to Board, effective February 5, 2026.
Mettler-Toledo Q3 adjusted EPS $11.15 (+9% YoY); adds $2.75B buyback; raises FY guidance
Q3 reported sales $1,029.7M (+8% reported, +6% local currency); Americas LC +10%, Europe +6%, Asia/Rest +1%.
Base salary halved to EUR 140,000 for 2026; executive works at 50% time commitment.
Mettler-Toledo appoints Pablo Perversi, Danone Europe President, to Board of Directors
Pablo Perversi appointed to MTD Board, effective November 6, 2025; board expands from 8 to 9 seats.
Mettler-Toledo Q2 adjusted EPS $10.09 (+5% YoY); raises FY25 guidance
Q2 reported sales $983.2M (+4% YoY); local currency sales +2%; GAAP EPS $9.76, prior year had $1.07 tax benefit.
Mettler-Toledo grants 2025 LTI awards; CEO target up ~5%, NEOs up ~10%
CEO Patrick Kaltenbach receives 679 PSUs, 1,855 options, 728 RSUs in May 2025 grant.
Mettler-Toledo annual meeting: all 8 directors elected; Say-on-Pay passes 87%
All eight director nominees elected; Thomas P. Salice received 16.8M for, 1.6M against.
Mettler-Toledo Q1 adjusted EPS $8.19, down 8% YoY; cuts FY2025 guidance on tariff costs
Q1 reported sales $883.7M, -5% YoY; local currency sales -3% (+3% ex-delayed shipments).
Mettler-Toledo Q4 EPS $11.96, adj. EPS $12.41 (+32%); guides FY25 adj. EPS $42.35-$43.00
Q4 reported sales $1.045B, +12% local currency; Americas +7%, Europe +19%, Asia/RoW +14%.
Mettler Toledo issues €100M 3.80% senior notes due 2035
Issued €100M aggregate principal of 3.80% Series 2025-A Senior Notes due July 9, 2035, in private placement.
Mettler-Toledo Q3 adjusted EPS $10.21, +4% YoY; guides FY24 EPS $40.35-$40.50
Q3 reported sales $954.5M (+1% YoY); GAAP EPS $9.96 vs $9.21; adjusted EPS $10.21 vs $9.80.
Mettler-Toledo Q2 sales down 4% to $946.8M; adjusted EPS $9.65; raises full-year guidance
Reported Q2 sales $946.8M, down 4% YoY; local currency sales down 2%. Asia/Rest of World declined 12% in local currency, while Europe grew 6%.
Mettler Toledo appoints Brian Shepherd to Board of Directors effective July 2, 2024
Brian Shepherd appointed as independent director; board expands from 8 to 9 members.
Mettler-Toledo upsizes credit facility to $1.35B, extends maturity to 2029
Revolving credit facility increased from $1.25B to $1.35B; maturity extended to 2029 with option for two-year extension.
Mettler-Toledo annual meeting results: all directors elected, say-on-pay approved with 84% support
Eight director nominees elected; Thomas P. Salice received 17.1M for, 2.0M against, highest opposition.
Mettler-Toledo Q1 sales flat $925.9M; adjusted EPS $8.89 (+2%); raises FY guidance
GAAP EPS $8.24 vs $8.47 prior year; sales flat at $925.9M; adjusted EPS $8.89 (+2% YoY).
Mettler-Toledo Q4 GAAP EPS $8.52, adj EPS $9.40; sales down 12%; guides FY24 above prior
Q4 GAAP EPS $8.52 vs $11.86 YoY; Adjusted EPS $9.40 vs $12.10; sales $935M, -12% reported.
Mettler-Toledo files Q4 2023 financial update at J.P. Morgan conference; figures unknown
Filed 8-K with new financial information for quarter ended Dec 31, 2023, presented at J.P. Morgan Healthcare Conference.
Mettler-Toledo warns Q4 sales decline ~13% local currency, below guidance; withdraws EPS forecast
Preliminary Q4 2023 local currency sales decline ~13%, worse than prior guidance of -7% to -8%.
Mettler-Toledo board chair Robert Spoerry to retire; Roland Diggelmann nominated
Robert F. Spoerry to retire after 40 years; will not stand for re-election at May 9, 2024 annual meeting.
Mettler-Toledo grants CEO Patrick Kaltenbach 976 RSUs and up to 3,756 performance stock options
976 restricted stock units vesting over 3 years (one-third annually per grant anniversary).
Mettler-Toledo Q3 sales -4% to $942.5M; cuts 2023 Adj EPS guidance to $39.10-$39.30
Q3 reported sales $942.5M (-4% YoY); local currency sales -5%; Adj EPS $9.80 vs $10.18 (-4%).
Mettler-Toledo board confirms annual Say-on-Pay votes through 2029
Board determined future Say-on-Pay advisory votes will be held annually, following stockholder recommendation from May 4, 2023 annual meeting.
Mettler-Toledo corrects immaterial non-GAAP local currency sales growth figures for Q2 2023
Corrected Swiss Operations total net sales local-currency growth: (15)% for three months ended June 30, 2023.
Mettler Toledo appoints Wolfgang Wienand to Board of Directors effective Nov 1, 2023
Wolfgang Wienand, CEO of Siegfried Holding AG (CDMO for pharma), appointed to board effective Nov 1, 2023.
Mettler-Toledo Q2 adjusted EPS $10.19, slashes FY guidance to $40.30-$41.20
Q2 GAAP EPS $9.69; adjusted EPS $10.19 (+9% YoY); revenue $982.1M flat YoY.
Mettler-Toledo amends $1.25B credit facility, replaces LIBOR with SOFR, adds Safeline as borrower
Amendment No. 6 to $1.25B unsecured revolving credit facility, dated May 17, 2023.
All eight director nominees elected; Thomas Salice received the lowest support (17.4M for, 2.38M against).
Mettler-Toledo Q1 adj EPS $8.69 (+10% YoY); sales +7% LC; raises FY guidance
Reported sales $929M (+3% reported, +7% LC); currency headwind -4%.
Mettler-Toledo Q4 2022 adj EPS $12.10 (+15% YoY); FY2023 guidance raised
Q4 adjusted EPS $12.10, up 15% from $10.53; GAAP EPS $11.86 vs $9.94.
Mettler Toledo issues $150M 5.45% Senior Notes due 2033
Issued $150M aggregate principal of 5.45% Series 2023-A Senior Notes, maturing March 1, 2033.
Mettler Toledo director Olivier Filliol will not stand for re-election in May 2023
Olivier Filliol, former CEO and board member since 2009, notified company on Nov 21, 2022, he will not stand for re-election at May 2023 annual meeting.
Mettler Toledo appoints Ingrid Zhang to board, Chu to retire May 2023
Ingrid Zhang appointed to Board, effective Feb 1, 2023; qualifies as independent director.
Q3 adjusted EPS $10.18 beats prior year; guides FY22 adj EPS $38.95-$39.05; adds $2.5B buyback
Q3 reported sales $985.8M (+4% reported, +10% local currency); GAAP EPS $9.76, adjusted EPS $10.18 (+17% YoY).
Mettler-Toledo appoints Roland Diggelmann to Board of Directors
Roland Diggelmann appointed as independent director, effective August 1, 2022.
Mettler-Toledo Q2 adjusted EPS $9.39, up 16% YoY; raises FY2022 guidance
Reported sales $978.4M (+10% local currency); Adjusted EPS $9.39 vs $8.10 prior year.
Mettler-Toledo annual meeting elects all director nominees; say-on-pay passes with 88% support
All 8 director nominees elected; Thomas P. Salice received highest opposition (3,788,680 votes against).
Mettler-Toledo Q1 adj. EPS $7.87, up 20% YoY; raises FY sales growth outlook to ~8%
Reported sales $897.8M, +12% reported / +14% local currency; GAAP EPS $7.55 vs $6.32.
Mettler Toledo Lab Division Head Aggersbjerg to resign Feb 2023; successor named
Peter Aggersbjerg, Head of Divisions and Laboratory Division, resigns effective Feb 28, 2023.
Mettler-Toledo Q4 adj EPS $10.53 beats $9.26 YoY; guides 2022 above prior expectations
Q4 GAAP EPS $9.94 vs $9.03 YoY; adjusted EPS $10.53 (+14% vs $9.26).
Mettler-Toledo issues $300M in senior notes; amends existing note covenants
Issued $150M 2.81% Series 2022-A Notes due 2037 and $150M 2.91% Series 2022-B Notes due 2037.
Q3 reported sales $952M (+18% YoY); local currency sales +16%.
Mettler-Toledo Q2 sales up 34%, Adj EPS $8.10 vs $5.29; raises FY Adj EPS guidance to $32.60-$32.90
Q2 reported sales $924.4M (+34% YoY); local currency sales +27%; GAAP EPS $7.85 vs $5.22.
On June 26, 2024, the Board of Directors of Mettler-Toledo International Inc. (the "Company") announced it has appointed Brian Shepherd as a director of the Company, effective July 2, 2024, and determined Mr. Shepherd qualifies as an "independent director" for purposes of the New York Stock Exchange listing standards.
Board Chair Robert F. Spoerry will retire and not stand for re-election to the Board of Directors at the annual meeting of shareholders on May 9, 2024
announced it has appointed Wolfgang Wienand as a director of the Company, effective November 1, 2023
On November 21, 2022, Olivier Filliol notified Mettler-Toledo International Inc. (the “Company”) that he will not stand for re-election at the Annual Meeting of Shareholders of the Company to be held in May 2023
the Board of Directors of Mettler-Toledo International Inc. (the “Company”) announced it has appointed Ingrid Zhang as a director of the Company, effective February 1, 2023
the Company also announced that Wah-Hui Chu will retire from the Board of Directors effective May 2023
announced it has appointed Roland Diggelmann as a director of the Company, effective August 1, 2022
On February 22, 2022, Peter Aggersbjerg, Head of Divisions and with direct responsibility for the Laboratory Division, notified Mettler-Toledo International Inc. that he will resign in approximately one year, effective February 28, 2023, to pursue future career opportunities.
Mr. Aggersbjerg will stay in his current role and work closely with the future Head of the Laboratory Division, Stefan Heiniger, (currently Head of Laboratory Weighing) on transitioning his responsibilities.
Max materiality 0.90 · Median 0.55 · Most common event earnings